BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2690263)

  • 1. [Local factors in bone repair].
    Bergmann P
    Rev Med Brux; 1989 Dec; 10(10):419-23. PubMed ID: 2690263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of growth factors on bone cell replication and differentiation.
    Canalis E
    Clin Orthop Relat Res; 1985 Mar; (193):246-63. PubMed ID: 3882294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor necrosis factors alpha and beta induce osteoblastic cells to stimulate osteoclastic bone resorption.
    Thomson BM; Mundy GR; Chambers TJ
    J Immunol; 1987 Feb; 138(3):775-9. PubMed ID: 3805716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoclast-derived activity in the coupling of bone formation to resorption.
    Martin TJ; Sims NA
    Trends Mol Med; 2005 Feb; 11(2):76-81. PubMed ID: 15694870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage colony-stimulating factor and interleukin-6 release by periprosthetic cells stimulates osteoclast formation and bone resorption.
    Neale SD; Sabokbar A; Howie DW; Murray DW; Athanasou NA
    J Orthop Res; 1999 Sep; 17(5):686-94. PubMed ID: 10569477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
    Pederson L; Winding B; Foged NT; Spelsberg TC; Oursler MJ
    Cancer Res; 1999 Nov; 59(22):5849-55. PubMed ID: 10582709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone explants is associated with suppression of osteoclastic bone resorption.
    Löwik CW; Nibbering PH; van de Ruit M; Papapoulos SE
    J Clin Invest; 1994 Apr; 93(4):1465-72. PubMed ID: 8163651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow cells produce soluble factors that inhibit osteoclast activity.
    Ninomiya JT; Bi Y; Banks MA; Lavish SA; Goldberg VM; Greenfield EM
    J Orthop Res; 1999 Jan; 17(1):51-8. PubMed ID: 10073647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of TGF-beta on bone.
    Mundy GR
    Ciba Found Symp; 1991; 157():137-43; discussion 143-51. PubMed ID: 2070682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
    Chirgwin JM; Guise TA
    Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen stimulates the elaboration of cell/matrix surface-associated inhibitory factor of osteoclastic bone resorption from osteoblastic cells.
    Ishii T; Saito T; Morimoto K; Takeuchi Y; Asano S; Kumegawa M; Ogata E; Matsumoto T
    Biochem Biophys Res Commun; 1993 Mar; 191(2):495-502. PubMed ID: 8461006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity.
    Martin TJ; Ng KW
    J Cell Biochem; 1994 Nov; 56(3):357-66. PubMed ID: 7876329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphology and biochemistry of bone remodeling: possible control by vitamin D, parathyroid hormone, and other substances.
    Huffer WE
    Lab Invest; 1988 Oct; 59(4):418-42. PubMed ID: 3050272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Continuous remodeling of the skeleton. Growth factors and cytokines direct the activity].
    Ljunggren O; Ljunghall S; Lerner U
    Lakartidningen; 1995 May; 92(20):2094-6, 2099-100. PubMed ID: 7760596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physiopathological basis of bone turnover.
    Masi L; Brandi ML
    Q J Nucl Med; 2001 Mar; 45(1):2-6. PubMed ID: 11456372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
    Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
    Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytokines, growth factors, and metabolic bone disease].
    Pumarino H; Pumarino MG
    Rev Med Chil; 1996 Feb; 124(2):248-57. PubMed ID: 9213895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of osteoclast mediated bone resorption--rationale for the design of new therapeutics.
    Väänänen K
    Adv Drug Deliv Rev; 2005 May; 57(7):959-71. PubMed ID: 15876398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone growth factors.
    Mohan S; Baylink DJ
    Clin Orthop Relat Res; 1991 Feb; (263):30-48. PubMed ID: 1993386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,25-Dihydroxyvitamin D3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption.
    McSheehy PM; Chambers TJ
    J Clin Invest; 1987 Aug; 80(2):425-9. PubMed ID: 3611354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.